Literature DB >> 271037

Paraparesis following intrathecal cytosine arabinoside: a case report with neuropathologic findings.

A C Breuer, S W Pitman, D M Dawson, W C Schoene.   

Abstract

A 65-year-old white male with acute myelogenous leukemia received whole brain irradiation (2550 rads) and intrathecal cytosine arabinoside for CNS prophylaxis. Bone marrow remission had been previously achieved with systemic chemotherapy (vincristine, Adriamycin, prednisone, and cytosine arabinoside). Two weeks following the last intrathecal cytosine arabinoside treatment, the patient developed a spastic paraparesis requiring the use of a walker. A gas myelogram was normal and CSF examination revealed a protein of 50 mg/100 ml but was otherwise unremarkable. Five months later, the patient had improved in that he could stand on his own. A relapse of his leukemia subsequently occurred and the patient died the following month. Striking degenerative changes were found in the spinal cord at postmortem examination. These included microvacuolization, axonal swellings, and loss of myelin with scattered macrophages laden with fat.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 271037     DOI: 10.1002/1097-0142(197712)40:6<2817::aid-cncr2820400611>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Atypical MRI findings in treatment-related leukoencephalopathy: case report.

Authors:  Y Ohmoto; K Kajiwara; S Kato; T Nisizaki; H Ito; S Tamura
Journal:  Neuroradiology       Date:  1996-02       Impact factor: 2.804

Review 2.  The toxicity of cytarabine.

Authors:  J Stentoft
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

3.  Necrotizing myelopathy associated with acute lymphoblastic leukemia. Case report and review of literature.

Authors:  W Grisold; D Lutz; D Wolf
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

4.  Irreversible paraplegia following one time prophylactic intrathecal chemotherapy in an adult patient with acute lymphoblastic leukemia.

Authors:  Hea Yong Lee; Sung-il Im; Myoung-Hee Kang; Kwang Min Kim; Seok Hyun Kim; Hun-Gu Kim; Jung Hun Kang; Gyeong-Won Lee
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

5.  Acute neurological toxicity of intrathecal cytosine arabinoside. A case report.

Authors:  S M Crawford; G J Rustin; K D Bagshawe
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  Acute reversible neurological deficit following intrathecal chemotherapy.

Authors:  H Dunkelman; H M Earl; C Twelves
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

7.  Lateral and dorsal column hyperintensity on magnetic resonance imaging in a patient with myelopathy associated with intrathecal chemotherapy.

Authors:  Fumine Saito; Taku Hatano; Masaaki Hori; Miwako Kawamura; Makoto Sasaki; Shigeki Aoki; Nobutaka Hattori
Journal:  Case Rep Neurol       Date:  2013-06-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.